Your browser doesn't support javascript.
loading
Reprogramming of the heavy-chain CDR3 regions of a human antibody repertoire.
Ou, Tianling; He, Wenhui; Quinlan, Brian D; Guo, Yan; Tran, Mai H; Karunadharma, Pabalu; Park, Hajeung; Davis-Gardner, Meredith E; Yin, Yiming; Zhang, Xia; Wang, Haimin; Zhong, Guocai; Farzan, Michael.
Afiliación
  • Ou T; Department of Microbiology and Immunology, The Scripps Research Institute, Jupiter, FL 33458, USA.
  • He W; Department of Microbiology and Immunology, The Scripps Research Institute, Jupiter, FL 33458, USA.
  • Quinlan BD; Department of Microbiology and Immunology, The Scripps Research Institute, Jupiter, FL 33458, USA.
  • Guo Y; Department of Microbiology and Immunology, The Scripps Research Institute, Jupiter, FL 33458, USA.
  • Tran MH; Department of Microbiology and Immunology, The Scripps Research Institute, Jupiter, FL 33458, USA.
  • Karunadharma P; Genomics Core, The Scripps Research Institute, Jupiter, FL 33458, USA.
  • Park H; X-ray Crystallography Core, The Scripps Research Institute, Jupiter, FL 33458, USA.
  • Davis-Gardner ME; The Yerkes National Primate Research Center, Emory University, Atlanta, GA 30329, USA.
  • Yin Y; Department of Microbiology and Immunology, The Scripps Research Institute, Jupiter, FL 33458, USA.
  • Zhang X; Department of Microbiology and Immunology, The Scripps Research Institute, Jupiter, FL 33458, USA.
  • Wang H; Institute of Chemical Biology, Shenzhen Bay Laboratory, Shenzhen, China.
  • Zhong G; Institute of Chemical Biology, Shenzhen Bay Laboratory, Shenzhen, China; School of Biology and Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, China.
  • Farzan M; Department of Microbiology and Immunology, The Scripps Research Institute, Jupiter, FL 33458, USA. Electronic address: mfarzan@scripps.edu.
Mol Ther ; 30(1): 184-197, 2022 01 05.
Article en En | MEDLINE | ID: mdl-34740791
B cells have been engineered ex vivo to express an HIV-1 broadly neutralizing antibody (bNAb). B cell reprograming may be scientifically and therapeutically useful, but current approaches limit B cell repertoire diversity and disrupt the organization of the heavy-chain locus. A more diverse and physiologic B cell repertoire targeting a key HIV-1 epitope could facilitate evaluation of vaccines designed to elicit bNAbs, help identify more potent and bioavailable bNAb variants, or directly enhance viral control in vivo. Here we address the challenges of generating such a repertoire by replacing the heavy-chain CDR3 (HCDR3) regions of primary human B cells. To do so, we identified and utilized an uncharacterized Cas12a ortholog that recognizes PAM motifs present in human JH genes. We also optimized the design of 200 nucleotide homology-directed repair templates (HDRT) by minimizing the required 3'-5' deletion of the HDRT-complementary strand. Using these techniques, we edited primary human B cells to express a hemagglutinin epitope tag and the HCDR3 regions of the bNAbs PG9 and PG16. Those edited with bNAb HCDR3 efficiently bound trimeric HIV-1 antigens, implying they could affinity mature in vivo in response to the same antigens. This approach generates diverse B cell repertoires recognizing a key HIV-1 neutralizing epitope.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Infecciones por VIH / VIH-1 Límite: Humans Idioma: En Revista: Mol Ther Asunto de la revista: BIOLOGIA MOLECULAR / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Infecciones por VIH / VIH-1 Límite: Humans Idioma: En Revista: Mol Ther Asunto de la revista: BIOLOGIA MOLECULAR / TERAPEUTICA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos